Results 271 to 280 of about 1,011,787 (303)
Some of the next articles are maybe not open access.
The Indian Journal of Pediatrics, 2011
As the first wave of biopharmaceuticals is expiring, biosimilars or follow-on -protein products (FOPP's) have emerged. Biosimilar drugs are cheaper than the originator/comparator drug. The regulatory foundation for these products is more advanced and better codified in Europe than in the US.
openaire +2 more sources
As the first wave of biopharmaceuticals is expiring, biosimilars or follow-on -protein products (FOPP's) have emerged. Biosimilar drugs are cheaper than the originator/comparator drug. The regulatory foundation for these products is more advanced and better codified in Europe than in the US.
openaire +2 more sources
Growth hormone and growth hormone releasing hormone
1989M.O. Thorner +10 more
openaire +1 more source
Hormone replacement therapy in cancer survivors: a con opinion
Ca-A Cancer Journal for Clinicians, 1996Carolyn D Runowicz
exaly

